Prosecution Insights
Last updated: April 19, 2026

Medicovestor Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
3
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19055378 METHODS OF ENHANCING EFFICACY OF IMMUNOCONJUGATES USING PAIRED HUMAN ANTIBODIES TARGETED AT NON-OVERLAPPING B-CELL EPITOPES ON THE SAME ANTIGEN LI, RUIXIANG 1674 Final Rejection Feb 17, 2025
19002112 DIMERIC ANTIBODIES AND THEIR METHODS OF MANUFACTURE HUYNH, PHUONG N 1641 Final Rejection Dec 26, 2024
18964025 DIMERIC IMMUNOCONJUGATES FOR USE IN TREATING CANCERS AND METHODS OF USE STOICA, ELLY GERALD 1647 Final Rejection Nov 29, 2024

Managing Medicovestor Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month